The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium
- PMID: 19846871
- DOI: 10.4049/jimmunol.0901935
The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium
Abstract
Natural cytotoxicity receptors (including NKp30, NKp44, and NKp46 in humans and NKp46 in mice) are type I transmembrane proteins that signal NK cell activation via ITAM-containing adapter proteins in response to stress- and pathogen-induced ligands. Although murine NKp46 expression (encoded by Ncr1) was thought to be predominantly restricted to NK cells, the identification of distinct intestinal NKp46(+) cell subsets that express the transcription factor Rorc and produce IL-22 suggests a broader function for NKp46 that could involve intestinal homeostasis and immune defense. Using mice carrying a GFP-modified Ncr1 allele, we found normal numbers of gut CD3(-)GFP(+) cells with a similar cell surface phenotype and subset distribution in the absence of Ncr1. Splenic and intestinal CD3(-)NKp46(+) cell subsets showed distinct patterns of cytokine secretion (IFN-gamma, IL-22) following activation via NK1.1, NKp46, IL-12 plus IL-18, or IL-23. However, IL-22 production was sharply restricted to intestinal CD3(-)GFP(+) cells with the CD127(+)NK1.1(-) phenotype and could be induced in an Ncr1-independent fashion. Because NKp46 ligands can trigger immune activation in the context of infectious pathogens, we assessed the response of wild-type and Ncr-1-deficient Rag2(-/-) mice to the enteric pathogen Citrobacter rodentium. No differences in the survival or clinical score were observed in C. rodentium-infected Rag2(-/-) mice lacking Ncr1, indicating that NKp46 plays a redundant role in the differentiation of intestinal IL-22(+) cells that mediate innate defense against this pathogen. Our results provide further evidence for functional heterogeneity in intestinal NKp46(+) cells that contrast with splenic NK cells.
Similar articles
-
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.Immunity. 2008 Dec 19;29(6):958-70. doi: 10.1016/j.immuni.2008.11.001. Epub 2008 Dec 11. Immunity. 2008. PMID: 19084435
-
Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.Eur J Immunol. 2011 Mar;41(3):780-6. doi: 10.1002/eji.201040851. Epub 2011 Feb 1. Eur J Immunol. 2011. PMID: 21341264
-
Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.Gastroenterology. 2010 Sep;139(3):882-92, 892.e1-3. doi: 10.1053/j.gastro.2010.05.040. Epub 2010 Jun 1. Gastroenterology. 2010. PMID: 20638936
-
STAT3 and its activators in intestinal defense and mucosal homeostasis.Curr Opin Gastroenterol. 2010 Mar;26(2):109-15. doi: 10.1097/MOG.0b013e3283365279. Curr Opin Gastroenterol. 2010. PMID: 20040863 Review.
-
Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.Immunity. 2009 Jul 17;31(1):15-23. doi: 10.1016/j.immuni.2009.06.008. Immunity. 2009. PMID: 19604490 Review.
Cited by
-
Immunotherapeutic applications of NK cells.Pharmaceuticals (Basel). 2015 May 25;8(2):250-6. doi: 10.3390/ph8020250. Pharmaceuticals (Basel). 2015. PMID: 26020141 Free PMC article. Review.
-
Interleukin-22: a likely target for treatment of autoimmune diseases.Autoimmun Rev. 2014 Jun;13(6):615-20. doi: 10.1016/j.autrev.2013.11.008. Epub 2014 Jan 10. Autoimmun Rev. 2014. PMID: 24418299 Free PMC article. Review.
-
Distinct requirements for T-bet in gut innate lymphoid cells.J Exp Med. 2012 Dec 17;209(13):2331-8. doi: 10.1084/jem.20122097. Epub 2012 Dec 3. J Exp Med. 2012. PMID: 23209316 Free PMC article.
-
Colonization and effector functions of innate lymphoid cells in mucosal tissues.Microbes Infect. 2016 Oct;18(10):604-614. doi: 10.1016/j.micinf.2016.06.005. Epub 2016 Jun 27. Microbes Infect. 2016. PMID: 27365193 Free PMC article. Review.
-
Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.Trends Immunol. 2020 Aug;41(8):721-733. doi: 10.1016/j.it.2020.06.009. Epub 2020 Jul 6. Trends Immunol. 2020. PMID: 32646594 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous